Home › Funds › ACT CAPITAL MANAGEMENT, LLC › ABVX

ACT CAPITAL MANAGEMENT, LLC position in ABVX

ABIVAX SA · Health Care

ACT CAPITAL MANAGEMENT, LLC reported holding 97,000 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$12.9M, representing 8.44% of its reported portfolio and ranking #3 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed ABVX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)97.00K sh
Reported value held$12.93M
Portfolio Weight8.44%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACT CAPITAL MANAGEMENT, LLC's ABVX position evolved

ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in ABVX in Q4 2025 at 63,900 shares (US$8.6M). The position peaked in Q2 2026 at 97,000 shares, worth US$12.9M. Across 3 filings, ACT CAPITAL MANAGEMENT, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 97,000 shares valued at US$12.9M — an increase of 26,100 shares quarter over quarter.. Notable position changes include a 37% increase in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 63.90K $8.62M New
Q1 2026 70.90K $7.89M Add
Q2 2026 97.00K $12.93M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has ACT CAPITAL MANAGEMENT, LLC held ABVX?

ACT CAPITAL MANAGEMENT, LLC has disclosed ABVX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is ACT CAPITAL MANAGEMENT, LLC's current position in ABVX?

As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 97.00K shares of ABVX (ABIVAX SA), valued at $12.93M, representing 8.44% of its reported portfolio and ranking #3.

Has ACT CAPITAL MANAGEMENT, LLC been buying or selling ABVX?

In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC increased its position in ABVX. The position peaked in Q2 2026 at 97.00K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.